Search

Your search keyword '"Shariat S."' showing total 1,386 results

Search Constraints

Start Over You searched for: Author "Shariat S." Remove constraint Author: "Shariat S."
1,386 results on '"Shariat S."'

Search Results

4. Impact of disease volume on survival efficacy of triplet therapy for metastatic hormone-sensitive prostate cancer: A systematic review, meta-analysis, and network meta-analysis

5. Conditional cancer-specific survival in surgically treated retroperitoneal liposarcoma and leiomyosarcoma patients: A stage-specific analysis

6. Surgical experience and functional outcomes after laparoscopic and robot-assisted partial nephrectomy: Results from a multi-institutional collaboration

7. Comparing the performance of digital rectal examination and PSA as a screening test for prostate cancer: A systematic review and meta-analysis

8. Evaluation of cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: A systematic review, meta-analysis, and network meta-analysis

9. No impact of detrusor muscle absence in pTaHG urothelial bladder carcinoma first TURB

10. Oncologic outcomes of template vs. radio-guided salvage lymph node dissection for node-only recurrent prostate cancer: Results from a multi-institutional collaboration

11. Risk of upper urinary tract dissemination in cT3 bladder cancer patients treated with Double J stent versus nephrostomy tube prior to radical cystectomy

12. Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients

15. Can we rely on available models predicting pathological outcomes in prostate cancer patients staged with 68-Ga PSMA-PET/CT? External validation of the existing nomograms for extracapsular extension and seminal vesicle invasion at radical prostatectomy and development of a novel tool including intraprostatic SUVmax

18. Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor

20. Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy

22. Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy

23. Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought

24. Improving prediction of local stage by PSMA-PET: Development of a novel integrated tool for extracapsular extension and seminal vesicle invasion combining clinical and imaging features in localized prostate cancer

26. Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients

32. Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database

33. Résultats actualisés de survie sans maladie (DFS) de l’essai de phase 3 CheckMate 274, évaluant le nivolumab en adjuvant chez les patients atteints d’un carcinome urothélial infiltrant le muscle à haut risque de récidive (CUIM-HR) après exérèse complète

34. Absence de détrusor dans les tumeurs pTaHG : quel impact ?

35. Who is the right patient for salvage radical prostatectomy? oncological outcomes compared between EAU guidelines-compliant and non-compliant patients

36. Perioperative complications after radical cystectomy for bladder cancer: an international multicenter collaboration

37. Development and validation of a novel nomogram predicting long-term progression in patients treated with early salvage radiation therapy after radical prostatectomy: the key role of PSA kinetics

38. Does previous prostatic surgery affect the accuracy of multiparametric MRI in detecting clinically significant prostate cancer? Results from a single center, high volume series

39. How to optimize patient selection before salvage lymph node dissection for nodal recurrent prostate cancer: a novel risk stratification tool

40. Oncologic surveillance for variant histology upper tract urothelial carcinoma

41. Toxicity profile of immediate post-prostatectomy radiation therapy: results from a large multi-institutional series

42. Evaluating the impact of complications on survival outcomes in patients treated with radical cystectomy for bladder cancer. Results from an european multi-institutional collaboration (YAU urothelial cancer group)

43. Implementing the follow-up schedule after radical nephrouretrectomy for low risk upper tract urothelial carcinoma

44. Has the introduction of mpMRI in the diagnostic pathway of prostate cancer led to improved oncological outcomes after radical prostatectomy? Result from a large single-institutional series

45. Drop-out rates from active surveillance for disease progression remain consistent and not negligible over time. A plea for long-term assessment based on a large, prospectively collected active surveillance cohort

46. Comparative analyses of micro-ultrasound versus MRI-targeted biopsy for the diagnosis of clinically significant prostate cancer. Preliminary results from the prospective us-mirror trial

48. Delaying post-operative radiation therapy after radical prostatectomy is associated with increased functional outcomes: results from a large single, referral center series

49. Oncologic surveillance intensity for variant histology versus pure urothelial carcinoma of the bladder after radical cystectomy

50. What is the optimal management of nodal oligorecurrent prostate cancer? results from a large series of patients treated with salvage lymph node dissection

Catalog

Books, media, physical & digital resources